IMS Health Holdings (NYSE:IMS) encountered a rise of 42.3% or 887,180 shares in the short positions. The number escalated from 2,099,775 on May 31,2016 to 2,986,955 on June 15,2016. The final interest is 1.5% of the floated stock. The days to cover figure of 3 can be arrived using the average daily exchange of 1,188,612 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.
IMS Health Holdings (NYSE:IMS): The stock opened at $24.41 on Friday but the bulls could not build on the opening and the stock topped out at $24.83 for the day. The stock traded down to $24.38 during the day, due to lack of any buying support eventually closed down at $24.59 with a loss of -2.54% for the day. The stock had closed at $25.23 on the previous day. The total traded volume was 2,180,580 shares.
The company shares have dropped -19.38% from its 1 Year high price. On Jul 31, 2015, the shares registered one year high at $33.52 and the one year low was seen on Jan 28, 2016. The 50-Day Moving Average price is $25.28 and the 200 Day Moving Average price is recorded at $25.32.
IMS Health Holdings (NYSE:IMS) has tumbled 0.24% during the past week and has dropped 3% in the last 4 week period. The company has outperformed the S&P 500 by 1.41% in the past week but underperformed the index by 0.06% in the last 4 weeks.
IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.